Integrating data sources to create new drug development pathways for targeted therapies
How best to treat NRAS-mutated melanoma
Avelumab and pembrolizumab for the treatment of merkel cell carcinoma
Sandra D'Angelo et al.
New treatment approaches for Merkel cell carcinoma - checkpoint inhibitors
OPTiM trial update: T-VEC for the treatment of melanoma